Legend Biotech Announces U.S. FDA Clearance Of Ind Application For Solid Tumor Car-T, Lb1908 For Relapsed Or Refractory Gastric, Esophageal And Pancreatic Cancers
Legend Biotech Corp - ADR (LEGN) - Legend Biotech Announces U.S. FDA Clearance of Ind Application for Solid Tumor Car-t, Lb1908 for Relapsed Or Refractory Gastric, Esophageal and Pancreatic Cancers.